BioNTech SE (BNTX) EBT Margin Growth (1y) (2019 - 2025)
BioNTech SE (BNTX) EBT Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 813.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn | -5,037.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,037.00 |
| Sep 30, 2025 | -1,112.00 |
| Jun 30, 2025 | 47,170.00 |
| Mar 31, 2025 | -6,679.00 |
| Dec 31, 2024 | -1,953.00 |
| Sep 30, 2024 | -1,265.00 |
| Jun 30, 2024 | -38,031.00 |
| Mar 31, 2024 | -23,228.00 |
| Dec 31, 2023 | -2,931.00 |
| Sep 30, 2023 | -4,521.00 |
| Jun 30, 2023 | -31,835.00 |
| Mar 31, 2023 | -2,330.00 |
| Dec 31, 2022 | -1,105.00 |
| Sep 30, 2022 | -606.00 |
| Jun 30, 2022 | -322.00 |
| Mar 31, 2022 | -145.00 |
| Sep 30, 2021 | -23,073.00 |
| Jun 30, 2021 | -14,092.00 |
| Mar 31, 2021 | -11,261.00 |
| Sep 30, 2020 | 20,241.00 |